Therefore, high EZH2 can indicate lower PRC2 function, and our mouse model and in vitro data show that one result of lowering PRC2 function in KRAS-driven adenocarcinomas is to de-repress FOXP2. The gene discussed is KRAS; the disease is adenocarcinoma.